EUVIMEDEUVIMED entdecken
Open Access

Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam

Khanh Nc Duong iD, Dinh Van Nguyen iD, Nathorn Chaiyakunapruk iD, Richard E Nelson iD, Daniel C Malone iD

Pharmacogenomics · 2023

DOI: 10.2217/pgs-2023-0095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Khanh Nc Duong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome, Allopurinol, HLA-B Antigens, Cost-Benefit Analysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HLA-B*58:01 is strongly associated with allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in Vietnam. This study assessed the cost-effectiveness of this testing to prevent SJS/TEN.

Methods

A model was developed to compare three strategies: no screening, use allopurinol; HLA-B*58:01 screening; and no screening, use probenecid. A willingness-to-pay of three-times gross domestic product per capita was used.

Results

Compared with 'no screening, use allopurinol', 'screening' increased quality-adjusted life-years by 0.0069 with the incremental cost of Vietnam dong (VND) 14,283,633 (US$617), yielding an incremental cost-effectiveness ratio of VND 2,070,459,122 (US$89,398) per quality-adjusted life-year. Therefore, 'screening' was unlikely to be cost-effective under the current willingness-to-pay. Testing's cost-effectiveness may change with targeted high-risk patients, reimbursed febuxostat or lower probenecid prices.

Conclusion

The implementation of nationwide HLAB*58:01 testing before the use of allopurinol is not cost-effective, according to this analysis. This may be due to the lack of quality data on the effectiveness of testing and costing data in the Vietnamese population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stevens-Johnson SyndromeAllopurinolHLA-B AntigensCost-Benefit AnalysisHumansVietnamQuality-Adjusted Life YearsProbenecid

Stichwörter der Autor:innen

HLA-B*58:01Vietnamallopurinol-induced SJS/TENcost–effectivenessgenetic testing

Substanzen

AllopurinolHLA-B AntigensHLA-B*58:01 antigenProbenecid

Autor:innen und Institutionen

  • Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA.
  • Department of Internal Medicine, Respiratory, Allergy & Clinical Immunology Unit, Vinmec Healthcare System, Hanoi, Vietnam.
  • College of Health Sciences, Vin University, Hanoi, Vietnam.
  • Department of Medicine, Penn State University, Hershey, PA 17033, USA.
  • IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT 84108, USA.
  • Division of Epidemiology, School of Medicine, University of Utah, Salt Lake City, UT 84108, USA.

ORCID-Profile: Khanh Nc Duong, Dinh Van Nguyen, Nathorn Chaiyakunapruk, Richard E Nelson, Daniel C Malone

Förderung

  • NCATS NIH HHS

Zitieren

APA

Duong, K. N., Nguyen, D. V., Chaiyakunapruk, N., Nelson, R. E., & Malone, D. C. (2023). Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0095

Vancouver

Duong KN, Nguyen DV, Chaiyakunapruk N, Nelson RE, Malone DC. Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0095

BibTeX
@article{Duong2023,
  author = {Duong, Khanh Nc and Nguyen, Dinh Van and Chaiyakunapruk, Nathorn and Nelson, Richard E and Malone, Daniel C},
  title = {Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam},
  journal = {Pharmacogenomics},
  year = {2023},
  doi = {10.2217/pgs-2023-0095}
}
Kostenlos starten →